← Leaderboards
John Damrath
Indiana University Indianapolis
$256,018
Attributed
$256,018
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2019–23$100K$75K$50K$25K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$256,018 · 1
By mechanism
F30$256,018 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Sharon M Moe$24,308,038
- Paul Richard Territo$22,416,914
- Somenath Mitra$941,956
- William Anthony Truitt$5,880,598
- Roberto F. Machado$15,563,589
Others in their field
Other Emerging Leaders on “Bone Turnover”
- Jessie P Buckley · Johns Hopkins University$5,118,404
- Albert Shieh · University Of California Los Angeles$3,223,618
- Derek Hillstrom · Bone Health Technologies, Inc.$2,710,602
- Melody Y Zeng · Weill Medical Coll Of Cornell Univ$1,980,652
- Reyad A Elbarbary · Pennsylvania State Univ Hershey Med Ctr$1,978,928
- Viral N Shah · University Of Colorado Denver$1,877,128
Research focus
Bone TurnoverAdvanced Glycosylation End ProductsAffectAnalogAftercareAnimalsArchitectureAmericanBiochemicalBiochemistryBiological MarkersBiomedical EngineeringBiopsyBoneBone DensityBone DiseasesBone FragilityBone LossBone MassBone MatrixBone QualityBone StrengthBone TissueCalcium
Grant awards (5)
The Effect of Etelcalcetide on Bone-tissue Properties in End Stage Kidney Disease$52,694
F30 · FY2023 · DK · contact PI
The Effect of Etelcalcetide on Bone-tissue Properties in End Stage Kidney Disease$51,752
F30 · FY2022 · DK · contact PI
The Effect of Etelcalcetide on Bone-tissue Properties in End Stage Kidney Disease$51,036
F30 · FY2021 · DK · contact PI
The Effect of Etelcalcetide on Bone-tissue Properties in End Stage Kidney Disease$50,520
F30 · FY2020 · DK · contact PI
The Effect of Etelcalcetide on Bone-tissue Properties in End Stage Kidney Disease$50,016
F30 · FY2019 · DK · contact PI